The digital pathology market is revolutionizing the traditional one by converting the slides into digital forms for in-depth visualizations, which allows the use of artificial intelligence-based diagnostics, teleconsultations, and easy interfacing with other healthcare systems. Despite these benefits to the detection of diseases through accuracy, efficiency, and team work, the dilemmas being faced are the high initial costs, the necessity for the training of the staff, and worries over data security. On the whole, this technology is a groundbreaking step with the possibility of radically changing health care all over the world.
Key Growth Drivers and Opportunities
Growing Adoption of Telepathology: Telepathology, the remote viewing and sharing of digital pathology images, broadens the availability of skills that are highly specialized, facilitates the worldwide cooperation of pathologists, and improves the correct diagnostic, that is to say, an improvement of patient care and market growth for digital pathology, which is the ultimate goal of the digital pathology market.
Challenges
The digital pathology market is constrained in a number of ways including the expensive first investment for the sophisticated scanners and software, the requirement of a specially trained pathologist, security, and privacy concerns of data and also the technical challenge of efficiently handling the large image files.
Innovation and Expansion
For the First Time in History, Philips has Announced a Digital Pathology Scanner with Native, Adjustable DICOM JPEG and JPEG XL Output
In September 2025, Philips announced the addition of the Pathology Scanner SGi with adjustable DICOM JPEG and DICOM JPEG XL output to its lineup of SG300 and SG60 scanners. Consequently, it offers native DICOM JPEG XL output, making it the first in the world. Pathology labs can now store, handle, and analyze increasing amounts of digital pathology data and facilitate more efficient processes both on-premises and in the cloud thanks to DICOM JPEG XL output files, which are up to 50% smaller while maintaining the same excellent image quality.
Furthermore, by preserving radiology and pathology pictures in one place, the DICOM standard facilitates collaboration between pathology and other imaging modalities, scales cross-modality integrated diagnoses and decision-making, and consolidates IT infrastructure.
PathAI Advances AI-Powered Pathology with the Launch of the Precision Pathology Network
In July 2025, The Precision Pathology Network (PPN), a first-of-its-kind network of digital anatomic pathology labs driven by PathAI’s AISight 1 Image Management System (IMS), was introduced today by PathAI, a world leader in artificial intelligence (AI) and digital pathology solutions.
The PPN is intended to facilitate early access to the newest AI-powered pathology solutions created by PathAI in partnership with the biopharma sector, allow participating labs to profit from real-world pathology data, assist with evidence generation studies sponsored by biopharma, and facilitate innovative clinical development approaches that make use of AI-pathology.
Inventive Sparks, Expanding Markets
3DHistech Ltd., Definiens AG, Hamamatsu Photonics K.K., Leica Biosystems Nussloch GmBH, Mikroscan Technologies Inc., Nikon Corporation, Olympus Corporation, Koninklijke Philips NV, Ventana Medical Systems Inc., and VISIONPHARM are the major companies that operate the digital pathology market.
About Author:
Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.
